Literature DB >> 18793689

Kisspeptins and the control of gonadotropin secretion in male and female rodents.

J Roa1, J M Castellano, V M Navarro, D J Handelsman, L Pinilla, M Tena-Sempere.   

Abstract

Kisspeptins, the products of KiSS-1 gene acting via G protein-coupled receptor 54 (GPR54), have recently emerged as fundamental gatekeepers of gonadal function by virtue of their ability to stimulate gonadotropin secretion. Indeed, since the original disclosure of the reproductive facet of the KiSS-1/GPR54 system, an ever-growing number of studies have substantiated the extraordinary potency of kisspeptins to elicit gonadotropin secretion in different mammalian species, under different physiologic and experimental conditions, and through different routes of administration. In this context, studies conducted in laboratory rodents have been enormously instrumental to characterize: (i) the primary mechanisms of action of kisspeptins in the control of gonadotropin secretion; (ii) the pharmacological consequences of acute vs. continuous activation of GPR54; (iii) the roles of specific populations of kisspeptin-producing neurons at the hypothalamus in mediating the feedback effects of sex steroids; (v) the function of kisspeptins in the generation of the pre-ovulatory surge of gonadotropins; and (iv) the influence of sex steroids on GnRH/gonadotropin responsiveness to kisspeptins. While some of those aspects of kisspeptin function will be covered elsewhere in this Special Issue, we summarize herein the most salient data, obtained in laboratory rodents, that have helped to define the physiologic roles and putative pharmacological implications of kisspeptins in the control of male and female gonadotropic axis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793689     DOI: 10.1016/j.peptides.2008.08.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  27 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  The neuroendocrine basis of lactation-induced suppression of GnRH: role of kisspeptin and leptin.

Authors:  M Susan Smith; Cadence True; K L Grove
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

3.  Leptin action via LepR-b Tyr1077 contributes to the control of energy balance and female reproduction.

Authors:  Christa M Patterson; Eneida C Villanueva; Megan Greenwald-Yarnell; Michael Rajala; Ian E Gonzalez; Natinder Saini; Justin Jones; Martin G Myers
Journal:  Mol Metab       Date:  2012-07-26       Impact factor: 7.422

4.  Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park
Journal:  Hum Reprod Update       Date:  2020-09-01       Impact factor: 15.610

5.  Dominant Neuropeptide Cotransmission in Kisspeptin-GABA Regulation of GnRH Neuron Firing Driving Ovulation.

Authors:  Richard Piet; Bruna Kalil; Tim McLennan; Robert Porteous; Katja Czieselsky; Allan E Herbison
Journal:  J Neurosci       Date:  2018-06-13       Impact factor: 6.167

6.  Localization of gonadotropin-releasing hormone (GnRH), gonadotropin-inhibitory hormone (GnIH), kisspeptin and GnRH receptor and their possible roles in testicular activities from birth to senescence in mice.

Authors:  Shabana Anjum; Amitabh Krishna; Rajagopala Sridaran; Kazuyoshi Tsutsui
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2012-10-01

7.  Kisspeptin increases GnRH mRNA expression and secretion in GnRH secreting neuronal cell lines.

Authors:  Horacio J Novaira; Yewade Ng; Andrew Wolfe; Sally Radovick
Journal:  Mol Cell Endocrinol       Date:  2009-07-01       Impact factor: 4.102

8.  Disrupted kisspeptin signaling in GnRH neurons leads to hypogonadotrophic hypogonadism.

Authors:  Horacio J Novaira; Momodou L Sonko; Gloria Hoffman; Yongbum Koo; Chemyong Ko; Andrew Wolfe; Sally Radovick
Journal:  Mol Endocrinol       Date:  2014-01-01

9.  Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.

Authors:  Charlotte Sonigo; Justine Bouilly; Nadège Carré; Virginie Tolle; Alain Caraty; Javier Tello; Fabian-Jesus Simony-Conesa; Robert Millar; Jacques Young; Nadine Binart
Journal:  J Clin Invest       Date:  2012-09-24       Impact factor: 14.808

10.  A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10.

Authors:  Annette E Curtis; Jennifer H Cooke; Jordan E Baxter; James R C Parkinson; Attia Bataveljic; Mohammad A Ghatei; Stephen R Bloom; Kevin G Murphy
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.